首页 > 最新文献

Journal of the Formosan Medical Association最新文献

英文 中文
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C. 高正常和异常的丙氨酸转氨酶水平与慢性丙型肝炎治疗后肝癌风险增加有关。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-02-06 DOI: 10.1016/j.jfma.2025.01.026
Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing Tao Kuo, Lein-Ray Mo, Ching Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Kuo-Chih Tseng, Ming-Lung Yu

Background/purpose: The risk of hepatocellular carcinoma (HCC) is increased in patients with chronic hepatitis C (CHC) and elevated alanine transaminase (ALT) levels. The association between HCC and ALT levels after interferon (IFN) or direct-acting antivirals (DAA) therapy is unclear.

Methods: Patients with CHC receiving antiviral therapy were included in two large-scale cohorts in Taiwan (T-COACH and TACR). Posttreatment ALT levels were assessed at 24-weeks/12-weeks after the end-of-treatment with IFN/DAA. HCC risk after antiviral therapy were identified for evaluation.

Results: Of 29,926 CHC patients enrolled in the study, 64%, 22.5%, and 13.5% had posttreatment healthy-normal (female, ≤19 U/L; male ≤30 U/L), high-normal (female, 19-40 U/L; male, 30-40 U/L), and abnormal (>40 U/L) ALT levels, respectively. During a median follow-up of 2.4 years, 1245 patients developed HCC. The 5-year cumulative HCC incidence was 11.2% and 5.2% in the abnormal and high-normal ALT groups, respectively, compared to 2.7% in the healthy ALT group. In Cox regression analysis, factors associated with a higher HCC risk were advanced fibrosis, abnormal and high-normal posttreatment ALT levels, cirrhosis, and old age; whereas a sustained virological response (SVR) was associated with a lower HCC risk. The aforementioned impacts of abnormal and high-normal posttreatment ALT levels were observed across the SVR, non-SVR, and non-cirrhotic subgroups.

Conclusion: Patients with CHC with high-normal and abnormal posttreatment ALT levels have an increased risk of HCC; thus, HCC surveillance is still necessary in this population.

背景/目的:慢性丙型肝炎(CHC)和谷丙转氨酶(ALT)水平升高的患者发生肝细胞癌(HCC)的风险增加。干扰素(IFN)或直接抗病毒药物(DAA)治疗后HCC与ALT水平之间的关系尚不清楚。方法:将接受抗病毒治疗的CHC患者纳入台湾两个大型队列(T-COACH和TACR)。在治疗结束后24周/12周用IFN/DAA评估治疗后ALT水平。确定抗病毒治疗后HCC风险进行评估。结果:在纳入研究的29926例CHC患者中,64%、22.5%和13.5%的患者治疗后健康正常(女性,≤19 U/L;男≤30u /L),高正常(女,19- 40u /L;男性,30 ~ 40 U/L),异常(bb0 ~ 40 U/L)。在中位随访2.4年期间,1245名患者发生HCC。ALT异常组和高正常组的5年累积HCC发病率分别为11.2%和5.2%,而ALT健康组为2.7%。在Cox回归分析中,与HCC高风险相关的因素是晚期纤维化、治疗后ALT水平异常和高正常、肝硬化和老年;而持续的病毒学反应(SVR)与较低的HCC风险相关。在SVR、非SVR和非肝硬化亚组中观察到上述异常和高正常治疗后ALT水平的影响。结论:治疗后ALT水平高、异常的CHC患者发生HCC的风险增高;因此,HCC监测在这一人群中仍然是必要的。
{"title":"High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C.","authors":"Yen-Chun Chen, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing Tao Kuo, Lein-Ray Mo, Ching Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Kuo-Chih Tseng, Ming-Lung Yu","doi":"10.1016/j.jfma.2025.01.026","DOIUrl":"10.1016/j.jfma.2025.01.026","url":null,"abstract":"<p><strong>Background/purpose: </strong>The risk of hepatocellular carcinoma (HCC) is increased in patients with chronic hepatitis C (CHC) and elevated alanine transaminase (ALT) levels. The association between HCC and ALT levels after interferon (IFN) or direct-acting antivirals (DAA) therapy is unclear.</p><p><strong>Methods: </strong>Patients with CHC receiving antiviral therapy were included in two large-scale cohorts in Taiwan (T-COACH and TACR). Posttreatment ALT levels were assessed at 24-weeks/12-weeks after the end-of-treatment with IFN/DAA. HCC risk after antiviral therapy were identified for evaluation.</p><p><strong>Results: </strong>Of 29,926 CHC patients enrolled in the study, 64%, 22.5%, and 13.5% had posttreatment healthy-normal (female, ≤19 U/L; male ≤30 U/L), high-normal (female, 19-40 U/L; male, 30-40 U/L), and abnormal (>40 U/L) ALT levels, respectively. During a median follow-up of 2.4 years, 1245 patients developed HCC. The 5-year cumulative HCC incidence was 11.2% and 5.2% in the abnormal and high-normal ALT groups, respectively, compared to 2.7% in the healthy ALT group. In Cox regression analysis, factors associated with a higher HCC risk were advanced fibrosis, abnormal and high-normal posttreatment ALT levels, cirrhosis, and old age; whereas a sustained virological response (SVR) was associated with a lower HCC risk. The aforementioned impacts of abnormal and high-normal posttreatment ALT levels were observed across the SVR, non-SVR, and non-cirrhotic subgroups.</p><p><strong>Conclusion: </strong>Patients with CHC with high-normal and abnormal posttreatment ALT levels have an increased risk of HCC; thus, HCC surveillance is still necessary in this population.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"406-414"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143370781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concerns and opportunities in combining TORS and OPR for managing inflammation and oxidative stress in OSA. 联合tor和OPR治疗OSA患者炎症和氧化应激的关注和机遇。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-04-15 DOI: 10.1016/j.jfma.2025.04.010
Yingxue Hu, Qinghui Yang, Pingwei Ni, Xiao Liu
{"title":"Concerns and opportunities in combining TORS and OPR for managing inflammation and oxidative stress in OSA.","authors":"Yingxue Hu, Qinghui Yang, Pingwei Ni, Xiao Liu","doi":"10.1016/j.jfma.2025.04.010","DOIUrl":"10.1016/j.jfma.2025.04.010","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"481"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144041536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to "Concerns and opportunities in combining TORS and OPR for managing inflammation and oxidative stress in OSA". 作者回复:经口机器人手术的阻塞性睡眠呼吸暂停患者术后口咽康复可抑制氧化应激和炎症。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-05-24 DOI: 10.1016/j.jfma.2025.05.027
Yi-Ju Lai, Kun-Ling Tsai, Ching-Hsia Hung, Cheng-Yu Lin
{"title":"Response to \"Concerns and opportunities in combining TORS and OPR for managing inflammation and oxidative stress in OSA\".","authors":"Yi-Ju Lai, Kun-Ling Tsai, Ching-Hsia Hung, Cheng-Yu Lin","doi":"10.1016/j.jfma.2025.05.027","DOIUrl":"10.1016/j.jfma.2025.05.027","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"482"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144142876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between school calendar and youth suicide in Taiwan. 台湾校历与青少年自杀之关系。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-04-30 DOI: 10.1016/j.jfma.2025.04.027
Ying-Yeh Chen, Cheng-Fang Yen, Kevin Chien-Chang Wu, Ying-Chen Chi, Yi-Lung Chen

Background/purpose: In East Asian countries, the emphasis on academic achievement is pronounced. In recent years, rising youth suicide rates have raised concerns about a potential link to academic stress. The aim of this study was to explore the relationship between academic periods and student suicide rates.

Methods: Data on youth suicides (ages 12-21) from Taiwan's national cause-of-death file, spanning 2012-2022, were analyzed using Poisson regressions. The analysis was further stratified by sex and academic level.

Results: Among middle/high school students, suicide rates increased at the start of the second semester and slightly decreased during the winter break. No similar decline was observed during the summer break. Among undergraduate students, suicide rates also increased after the winter break, with an additional peak before the break. Male undergraduates showed decreased suicide rates during both winter and summer breaks, while female undergraduates showed no significant calendar-linked variation.

Conclusion: The association between academic periods and suicide rates differed by academic level and sex. A potential winter break effect, coinciding with the Lunar New Year, was observed in both middle/high school and undergraduate students. In contrast, a reduction in suicide rates during summer break was observed only among undergraduates, potentially reflecting sustained academic stress among middle/high school students even during summer break. Among undergraduates, only male students exhibited variations in suicide rates in accordance with the academic calendar, while no such variation was observed among female students. No sex-specific differences were identified in the middle/high school group.

背景/目的:在东亚国家,对学业成绩的重视是显而易见的。近年来,不断上升的青少年自杀率引起了人们对学业压力的潜在联系的担忧。本研究的目的是探讨学习时间与学生自杀率之间的关系。​分析进一步按性别和学术水平分层。结果:在初高中学生中,自杀率在第二学期开始时上升,在寒假期间略有下降。在暑假期间没有观察到类似的下降。本科生的自杀率在寒假后也有所上升,在寒假前又有一个高峰。在寒暑假期间,男性大学生的自杀率都有所下降,而女性大学生的自杀率则没有明显的变化。结论:学业时间与自杀率之间的关系因学业水平和性别而异。在初高中和本科学生中都观察到与农历新年相吻合的潜在寒假效应。相比之下,暑假期间自杀率的下降只在本科生中观察到,这可能反映了即使在暑假期间初中/高中学生也存在持续的学业压力。在本科生中,只有男学生的自杀率根据学历出现了变化,而在女学生中没有观察到这种变化。在初高中组中没有发现性别差异。
{"title":"The association between school calendar and youth suicide in Taiwan.","authors":"Ying-Yeh Chen, Cheng-Fang Yen, Kevin Chien-Chang Wu, Ying-Chen Chi, Yi-Lung Chen","doi":"10.1016/j.jfma.2025.04.027","DOIUrl":"10.1016/j.jfma.2025.04.027","url":null,"abstract":"<p><strong>Background/purpose: </strong>In East Asian countries, the emphasis on academic achievement is pronounced. In recent years, rising youth suicide rates have raised concerns about a potential link to academic stress. The aim of this study was to explore the relationship between academic periods and student suicide rates.</p><p><strong>Methods: </strong>Data on youth suicides (ages 12-21) from Taiwan's national cause-of-death file, spanning 2012-2022, were analyzed using Poisson regressions. The analysis was further stratified by sex and academic level.</p><p><strong>Results: </strong>Among middle/high school students, suicide rates increased at the start of the second semester and slightly decreased during the winter break. No similar decline was observed during the summer break. Among undergraduate students, suicide rates also increased after the winter break, with an additional peak before the break. Male undergraduates showed decreased suicide rates during both winter and summer breaks, while female undergraduates showed no significant calendar-linked variation.</p><p><strong>Conclusion: </strong>The association between academic periods and suicide rates differed by academic level and sex. A potential winter break effect, coinciding with the Lunar New Year, was observed in both middle/high school and undergraduate students. In contrast, a reduction in suicide rates during summer break was observed only among undergraduates, potentially reflecting sustained academic stress among middle/high school students even during summer break. Among undergraduates, only male students exhibited variations in suicide rates in accordance with the academic calendar, while no such variation was observed among female students. No sex-specific differences were identified in the middle/high school group.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"435-440"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143998635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-utility evaluation of mammography screening program in Taiwan based on real-world data accounting for false positives. 台湾乳房x线照相术筛检计画之成本-效用评估:基于真实世界资料考虑假阳性。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-05-12 DOI: 10.1016/j.jfma.2025.04.033
Chia-Ni Lin, Kuo-Ting Lee, Jung-Der Wang, Li-Jung Elizabeth Ku

Purpose: We estimated stage-specific loss of quality-adjusted life expectancy (loss-of-QALE) and weighted by stage distributions considering false-positive (FP) costs for cost-utility evaluation of mammography screening in Taiwan.

Methods: FP costs included related reimbursements by the National Health Insurance for inpatients' and outpatients' services within one year after positive screening without BC diagnosis. Using the EuroQol five dimensions questionnaire (EQ-5D-3L), we collected the utilities from 1,181 women who visited a medical center with 2,247 repeated measurements in 2011-2021. We used a rolling-over algorithm to extrapolate survival to lifetime to estimate QALEs by multiplying survival probability with utilities and the loss of QALEs by comparing with age- and calendar year-matched referents. We calculated the incremental cost-effectiveness ratio (ICER) yearly by comparing the stage proportion weighted sums of loss-of-QALE between women detected by screening versus non-screening within six-month observed intervals in 2004-2013.

Results: QALEs of stages I, II, III, and IV were 29.4, 25.0, 18.2, and 4.5 years, respectively, while loss-of-QALEs were 0.3, 4.2, 10.6, and 22.9 quality-adjusted life year (QALYs), respectively. A total of 355,489 (11.1 %) FP were found with an average cost of US$ 2,126 per screen-detected BC. After the nationwide promotion of mammography in 2010-2013, ICER was US$ 855 per QALY.

Conclusion: The mammography screening, which exceeded 530,000 women with a 22 % coverage rate, showed promising cost-utility; the ICER was about one-third of the willingness-to-pay (WTP) of one gross domestic product per QALY. Future studies are warranted to explore the saving of productivity loss from a societal perspective.

目的:我们评估台湾乳房x光筛检的成本-效用评估,并考虑假阳性(FP)成本,评估不同阶段的质量调整预期寿命损失(loss-of- qale),并以阶段分布加权。方法:计划生育费用包括国民健康保险对未经BC诊断的阳性筛查后一年内住院和门诊服务的相关报销。使用EuroQol五维度问卷(EQ-5D-3L),我们收集了2011-2021年间访问医疗中心的1,181名妇女的公用事业资料,并进行了2,247次重复测量。我们使用了一种滚动算法,通过将生存概率与效用相乘,并通过与年龄和日历年匹配的指标进行比较,来估算qale。我们通过比较2004-2013年6个月观察间隔内接受筛查和未接受筛查的女性之间qale损失的阶段比例加权总和,每年计算增量成本-效果比(ICER)。结果:I期、II期、III期和IV期的质量调整生命年(QALYs)分别为29.4、25.0、18.2和4.5年,而质量调整生命年损失(QALYs)分别为0.3、4.2、10.6和22.9年。共发现355,489例FP(11.1%),每例筛查出的BC的平均成本为2,126美元。2010-2013年在全国推广乳房x光检查后,ICER为每QALY 855美元。结论:乳房x线摄影筛查超过53万妇女,覆盖率为22%,具有良好的成本效益;ICER约为每QALY一个国内生产总值的支付意愿(WTP)的三分之一。未来的研究有必要从社会的角度探讨如何挽救生产力损失。
{"title":"Cost-utility evaluation of mammography screening program in Taiwan based on real-world data accounting for false positives.","authors":"Chia-Ni Lin, Kuo-Ting Lee, Jung-Der Wang, Li-Jung Elizabeth Ku","doi":"10.1016/j.jfma.2025.04.033","DOIUrl":"10.1016/j.jfma.2025.04.033","url":null,"abstract":"<p><strong>Purpose: </strong>We estimated stage-specific loss of quality-adjusted life expectancy (loss-of-QALE) and weighted by stage distributions considering false-positive (FP) costs for cost-utility evaluation of mammography screening in Taiwan.</p><p><strong>Methods: </strong>FP costs included related reimbursements by the National Health Insurance for inpatients' and outpatients' services within one year after positive screening without BC diagnosis. Using the EuroQol five dimensions questionnaire (EQ-5D-3L), we collected the utilities from 1,181 women who visited a medical center with 2,247 repeated measurements in 2011-2021. We used a rolling-over algorithm to extrapolate survival to lifetime to estimate QALEs by multiplying survival probability with utilities and the loss of QALEs by comparing with age- and calendar year-matched referents. We calculated the incremental cost-effectiveness ratio (ICER) yearly by comparing the stage proportion weighted sums of loss-of-QALE between women detected by screening versus non-screening within six-month observed intervals in 2004-2013.</p><p><strong>Results: </strong>QALEs of stages I, II, III, and IV were 29.4, 25.0, 18.2, and 4.5 years, respectively, while loss-of-QALEs were 0.3, 4.2, 10.6, and 22.9 quality-adjusted life year (QALYs), respectively. A total of 355,489 (11.1 %) FP were found with an average cost of US$ 2,126 per screen-detected BC. After the nationwide promotion of mammography in 2010-2013, ICER was US$ 855 per QALY.</p><p><strong>Conclusion: </strong>The mammography screening, which exceeded 530,000 women with a 22 % coverage rate, showed promising cost-utility; the ICER was about one-third of the willingness-to-pay (WTP) of one gross domestic product per QALY. Future studies are warranted to explore the saving of productivity loss from a societal perspective.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"441-448"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144032863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pioneering study in the role of Ribonuclease L in the development of gestational diabetes mellitus in pregnant women. 核糖核酸酶L在孕妇妊娠期糖尿病发展中的作用的开创性研究。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-02-15 DOI: 10.1016/j.jfma.2025.02.008
Yi-Yun Tai, Yi-Ting Wang, Hung-Yuan Li, Hui-Chuen Chen, Chi-Ling Chen, Shin-Yu Lin, Wei-Shiung Yang

Background: Gestational diabetes mellitus as a common pregnancy complication carries metabolic risks for both the mother and infant. We and others have shown that ribonuclease L (RNase-L, an innate immunity regulator) regulates adipogenesis and insulin sensitivity of skeletal muscle. We further showed that its serum level was reduced in human subjects with impaired fasting glucose and metabolic syndrome. In this study we investigated its levels in gestational diabetes mellitus.

Methods: A total of 82 pregnant women who have received a one-step 75g oral glucose tolerance test (OGTT) for Gestational diabetes mellitus diagnosis were enrolled in this study, and their serum RNase-L levels during pregnancy were examined. Serum RNase-L levels were compared between women who did and did not develop Gestational diabetes mellitus. The risk for Gestational diabetes mellitus with the change of serum RNase-L concentration was estimated using a binary logistic regression model adjusting for age and body mass index.

Results: During pregnancy, serum RNase-L levels tended to descend with gestational age (P-for-trend = 0.008). The mean of serum RNase-L in the 1st, 2nd, and 3rd trimesters of pregnancy were respectively lower in the Gestational diabetes mellitus group compared with the controls (1st trimester: 17.1 ± 8.4vs.19.3 ± 7.2 μg/ml, P=0.328; 2nd: 14.7 ± 5.9vs.18.6 ± 6.8 μg/ml, P=0.017; 3rd: 13.6 ± 2.8vs.16.0 ± 3.5 μg/ml, P=0.005).

Conclusion: This is the first study on how innate immune factor affect the pregnant women in developing GDM. The serum RNase-L levels were found to be negatively associated with GDM risk during pregnancy. This observation linked GDM with innate immunity and RNA metabolism in its pathophysiology.

背景:妊娠期糖尿病是一种常见的妊娠并发症,对母亲和婴儿都有代谢风险。我们和其他人已经表明,核糖核酸酶L (RNase-L,一种先天免疫调节剂)调节骨骼肌的脂肪生成和胰岛素敏感性。我们进一步发现,在空腹血糖和代谢综合征患者中,其血清水平降低。本研究探讨了其在妊娠期糖尿病中的水平。方法:选取82例接受一步75克口服葡萄糖耐量试验(OGTT)诊断妊娠期糖尿病的孕妇,检测其妊娠期血清RNase-L水平。比较了发生和未发生妊娠期糖尿病的妇女血清RNase-L水平。采用调整年龄和体重指数的二元logistic回归模型评估血清RNase-L浓度变化对妊娠期糖尿病风险的影响。结果:妊娠期血清RNase-L水平随胎龄呈下降趋势(p - to -trend = 0.008)。妊娠期糖尿病组妊娠1、2、3期血清RNase-L均值均低于对照组(妊娠1、2、3期:17.1±8.4vs.19.3±7.2 μg/ml, P=0.328;第二组:14.7±5.9vs.18.6±6.8 μg/ml, P=0.017;第3组:13.6±2.8vs.16.0±3.5 μg/ml, P=0.005)。结论:本研究首次探讨了先天免疫因子对妊娠期GDM的影响。血清RNase-L水平与妊娠期GDM风险呈负相关。这一观察结果将GDM与先天免疫和病理生理中的RNA代谢联系起来。
{"title":"Pioneering study in the role of Ribonuclease L in the development of gestational diabetes mellitus in pregnant women.","authors":"Yi-Yun Tai, Yi-Ting Wang, Hung-Yuan Li, Hui-Chuen Chen, Chi-Ling Chen, Shin-Yu Lin, Wei-Shiung Yang","doi":"10.1016/j.jfma.2025.02.008","DOIUrl":"10.1016/j.jfma.2025.02.008","url":null,"abstract":"<p><strong>Background: </strong>Gestational diabetes mellitus as a common pregnancy complication carries metabolic risks for both the mother and infant. We and others have shown that ribonuclease L (RNase-L, an innate immunity regulator) regulates adipogenesis and insulin sensitivity of skeletal muscle. We further showed that its serum level was reduced in human subjects with impaired fasting glucose and metabolic syndrome. In this study we investigated its levels in gestational diabetes mellitus.</p><p><strong>Methods: </strong>A total of 82 pregnant women who have received a one-step 75g oral glucose tolerance test (OGTT) for Gestational diabetes mellitus diagnosis were enrolled in this study, and their serum RNase-L levels during pregnancy were examined. Serum RNase-L levels were compared between women who did and did not develop Gestational diabetes mellitus. The risk for Gestational diabetes mellitus with the change of serum RNase-L concentration was estimated using a binary logistic regression model adjusting for age and body mass index.</p><p><strong>Results: </strong>During pregnancy, serum RNase-L levels tended to descend with gestational age (P-for-trend = 0.008). The mean of serum RNase-L in the 1st, 2nd, and 3rd trimesters of pregnancy were respectively lower in the Gestational diabetes mellitus group compared with the controls (1st trimester: 17.1 ± 8.4vs.19.3 ± 7.2 μg/ml, P=0.328; 2nd: 14.7 ± 5.9vs.18.6 ± 6.8 μg/ml, P=0.017; 3rd: 13.6 ± 2.8vs.16.0 ± 3.5 μg/ml, P=0.005).</p><p><strong>Conclusion: </strong>This is the first study on how innate immune factor affect the pregnant women in developing GDM. The serum RNase-L levels were found to be negatively associated with GDM risk during pregnancy. This observation linked GDM with innate immunity and RNA metabolism in its pathophysiology.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"421-426"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C". 对“慢性丙型肝炎治疗后高正常和异常的丙氨酸转氨酶水平与肝癌风险增加有关”的评论。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-06-21 DOI: 10.1016/j.jfma.2025.06.030
Ruyin Jia, Guoshu Xu
{"title":"Comment on \"High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C\".","authors":"Ruyin Jia, Guoshu Xu","doi":"10.1016/j.jfma.2025.06.030","DOIUrl":"10.1016/j.jfma.2025.06.030","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"473"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144369018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of ultrasound-guided piriformis muscle corticosteroid injection versus extracorporeal shockwave therapy in patients with piriformis syndrome: A randomized controlled trial. 超声波引导下梨状肌皮质类固醇注射与体外冲击波疗法对梨状肌综合征患者的疗效对比:随机对照试验。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-02-27 DOI: 10.1016/j.jfma.2025.01.020
Yu-Shan Fu, Kao-Shang Shih, Yu-Ting Lin, Lin-Fen Hsieh, Ya-Fang Liu, Yann-Rong Chen

Background: Piriformis syndrome (PS) is a condition that causes low back pain. Ultrasound-guided injection (USI) has become a popular option for diagnostic block and treatment. Extracorporeal shockwave therapy (ESWT) is widely used for treating musculoskeletal diseases. However, few studies have compared the therapeutic efficacy of local steroid injections and ESWT.

Objectives: To compare the therapeutic efficacy of local corticosteroid injections and ESWT against PS.

Methods: This prospective randomized controlled trial enrolled 70 patients, who were randomly divided into two groups: the ESWT and USI groups. The ESWT group was subjected to one session of ESWT, and the USI group received one USI. Patients in both groups performed home-based stretching exercises. Evaluations were conducted at baseline and 1 and 5 weeks after the intervention. The outcomes included the patients' pain scores on a visual analog scale (VAS), Oswestry Disability Index (ODI), hip range of motion, side effects, and self-evaluation data.

Results: The groups did not vary significantly in terms of demographics. Significant time effects were observed in both groups, indicating post-treatment improvements. Furthermore, significant group effects were discovered in ODI and VAS pain scores. However, determining the superiority of one treatment over the other was challenging because of significant pretreatment differences between the groups in terms of ODI and VAS pain scores. However, no significant between-group difference was noted in the improvement rate.

Conclusion: ESWT and USI appear to be effective in the treatment of PS. The levels of efficacy of the two treatment approaches may be similar.

Clinical trial registration number: NCT04684537.

背景:梨状肌综合征(PS)是一种引起腰痛的疾病。超声引导注射(USI)已成为诊断阻断和治疗的流行选择。体外冲击波疗法(ESWT)广泛应用于肌肉骨骼疾病的治疗。然而,很少有研究比较局部类固醇注射和ESWT的治疗效果。目的:比较局部皮质类固醇注射与ESWT治疗多发性硬化症的疗效。方法:本前瞻性随机对照试验纳入70例患者,随机分为ESWT组和USI组。ESWT组接受1次ESWT, USI组接受1次USI。两组患者都进行了基于家庭的伸展运动。在基线和干预后1周和5周进行评估。结果包括患者的视觉模拟量表(VAS)疼痛评分、Oswestry残疾指数(ODI)、髋关节活动范围、副作用和自我评价数据。结果:两组在人口统计学上没有显著差异。两组均观察到显著的时间效应,表明治疗后改善。此外,在ODI和VAS疼痛评分中发现了显著的组效应。然而,确定一种治疗优于另一种治疗是具有挑战性的,因为在ODI和VAS疼痛评分方面,两组之间的预处理存在显著差异。然而,两组间的改善率无显著差异。结论:ESWT和USI治疗PS似乎有效,两种治疗方法的疗效水平可能相似。临床试验注册号:NCT04684537。
{"title":"Efficacy of ultrasound-guided piriformis muscle corticosteroid injection versus extracorporeal shockwave therapy in patients with piriformis syndrome: A randomized controlled trial.","authors":"Yu-Shan Fu, Kao-Shang Shih, Yu-Ting Lin, Lin-Fen Hsieh, Ya-Fang Liu, Yann-Rong Chen","doi":"10.1016/j.jfma.2025.01.020","DOIUrl":"10.1016/j.jfma.2025.01.020","url":null,"abstract":"<p><strong>Background: </strong>Piriformis syndrome (PS) is a condition that causes low back pain. Ultrasound-guided injection (USI) has become a popular option for diagnostic block and treatment. Extracorporeal shockwave therapy (ESWT) is widely used for treating musculoskeletal diseases. However, few studies have compared the therapeutic efficacy of local steroid injections and ESWT.</p><p><strong>Objectives: </strong>To compare the therapeutic efficacy of local corticosteroid injections and ESWT against PS.</p><p><strong>Methods: </strong>This prospective randomized controlled trial enrolled 70 patients, who were randomly divided into two groups: the ESWT and USI groups. The ESWT group was subjected to one session of ESWT, and the USI group received one USI. Patients in both groups performed home-based stretching exercises. Evaluations were conducted at baseline and 1 and 5 weeks after the intervention. The outcomes included the patients' pain scores on a visual analog scale (VAS), Oswestry Disability Index (ODI), hip range of motion, side effects, and self-evaluation data.</p><p><strong>Results: </strong>The groups did not vary significantly in terms of demographics. Significant time effects were observed in both groups, indicating post-treatment improvements. Furthermore, significant group effects were discovered in ODI and VAS pain scores. However, determining the superiority of one treatment over the other was challenging because of significant pretreatment differences between the groups in terms of ODI and VAS pain scores. However, no significant between-group difference was noted in the improvement rate.</p><p><strong>Conclusion: </strong>ESWT and USI appear to be effective in the treatment of PS. The levels of efficacy of the two treatment approaches may be similar.</p><p><strong>Clinical trial registration number: </strong>NCT04684537.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"391-397"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143523737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-operative oropharyngeal rehabilitation suppress oxidative stress and inflammation in obstructive sleep apnea patients with transoral robotic surgery. 经口机器人手术后口咽康复对阻塞性睡眠呼吸暂停患者氧化应激和炎症的抑制作用。
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-03-14 DOI: 10.1016/j.jfma.2025.03.004
Yi-Ju Lai, Chung-Yi Li, Kun-Ling Tsai, Ching-Hsia Hung, Cheng-Yu Lin

Purpose: To demonstrate the effects of postoperative oropharyngeal rehabilitation on inflammatory mediators and antioxidant capacity in adults with obstructive sleep apnea.

Methods: This quasi-experimental study enrolled participants without blinding between January 2020 and December 2022. Patients with obstructive sleep apnea were divided into a conservative treatment group (n = 17), surgery group (n = 23), or surgery combined with oropharyngeal rehabilitation (surgery + rehabilitation) group (n = 19). Polysomnography data and the concentration of inflammatory mediators and antioxidant capacity were determined at baseline, after 6 weeks of treatment, and after 18 weeks of treatment.

Results: Posttreatment percent changes in the apnea-hypopnea index in rapid eye movement sleep were positively correlated with that of IL-6 (0.641, 95% CI: 0.598 to 0.685; P < 0.001). Compared with the patients in the control group, those in the surgery + rehabilitation group had significantly reduced posttreatment percent changes in IL-6 (-77.273, 95% CI: -144.580 to -9.966; P = 0.024). In addition, the concentrations of IL-6 (-3.423, 95% CI: -6.638 to -0.207; P = 0.037) and matrix metallopeptidase-9 (-20.517, 95% CI: -40.584 to -0.450; P = 0.045) significantly decreased in the surgery + rehabilitation group. The total antioxidant capacity significantly improved in the surgery + rehabilitation group compared with in the surgery-only group (0.034, 95% CI: 0.005 to 0.063; P = 0.020).

Conclusion: The results reveal that postoperative oropharyngeal rehabilitation can reduce the serum levels of inflammatory mediators and increase antioxidant capacity. The combined treatment is more effective than surgery-only or conservative treatment.

目的:探讨阻塞性睡眠呼吸暂停患者术后口咽康复对炎症介质和抗氧化能力的影响。方法:这项准实验研究在2020年1月至2022年12月期间招募了非盲法参与者。将阻塞性睡眠呼吸暂停患者分为保守治疗组(n = 17)、手术组(n = 23)、手术联合口咽康复(手术+康复)组(n = 19)。在基线、治疗6周后和治疗18周后测定多导睡眠图数据、炎症介质浓度和抗氧化能力。结果:治疗后快速眼动睡眠呼吸暂停低通气指数的百分比变化与IL-6的百分比变化呈正相关(0.641,95% CI: 0.598 ~ 0.685;结论:术后口咽康复可降低血清炎症介质水平,提高抗氧化能力。联合治疗比单纯手术或保守治疗更有效。
{"title":"Post-operative oropharyngeal rehabilitation suppress oxidative stress and inflammation in obstructive sleep apnea patients with transoral robotic surgery.","authors":"Yi-Ju Lai, Chung-Yi Li, Kun-Ling Tsai, Ching-Hsia Hung, Cheng-Yu Lin","doi":"10.1016/j.jfma.2025.03.004","DOIUrl":"10.1016/j.jfma.2025.03.004","url":null,"abstract":"<p><strong>Purpose: </strong>To demonstrate the effects of postoperative oropharyngeal rehabilitation on inflammatory mediators and antioxidant capacity in adults with obstructive sleep apnea.</p><p><strong>Methods: </strong>This quasi-experimental study enrolled participants without blinding between January 2020 and December 2022. Patients with obstructive sleep apnea were divided into a conservative treatment group (n = 17), surgery group (n = 23), or surgery combined with oropharyngeal rehabilitation (surgery + rehabilitation) group (n = 19). Polysomnography data and the concentration of inflammatory mediators and antioxidant capacity were determined at baseline, after 6 weeks of treatment, and after 18 weeks of treatment.</p><p><strong>Results: </strong>Posttreatment percent changes in the apnea-hypopnea index in rapid eye movement sleep were positively correlated with that of IL-6 (0.641, 95% CI: 0.598 to 0.685; P < 0.001). Compared with the patients in the control group, those in the surgery + rehabilitation group had significantly reduced posttreatment percent changes in IL-6 (-77.273, 95% CI: -144.580 to -9.966; P = 0.024). In addition, the concentrations of IL-6 (-3.423, 95% CI: -6.638 to -0.207; P = 0.037) and matrix metallopeptidase-9 (-20.517, 95% CI: -40.584 to -0.450; P = 0.045) significantly decreased in the surgery + rehabilitation group. The total antioxidant capacity significantly improved in the surgery + rehabilitation group compared with in the surgery-only group (0.034, 95% CI: 0.005 to 0.063; P = 0.020).</p><p><strong>Conclusion: </strong>The results reveal that postoperative oropharyngeal rehabilitation can reduce the serum levels of inflammatory mediators and increase antioxidant capacity. The combined treatment is more effective than surgery-only or conservative treatment.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"459-467"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A bibliometric analysis of primary health care publication trends in the Asia-Pacific region from 2011 to 2023. 2011年至2023年亚太地区初级卫生保健出版物趋势的文献计量学分析
IF 2.5 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-04-01 Epub Date: 2025-03-02 DOI: 10.1016/j.jfma.2025.02.028
Chun-Feng Huang, Brian Bih-Jeng Chang, I-Hsuan Hwang, Yu-Chun Chen, Shinn-Jang Hwang

Background: Emphasis on primary health care (PHC) is the most efficient and economical approach to achieving universal health coverage, and should serve as its foundation. The aim of the study is to examine academic publications from 2011 to 2023 in the Asia-Pacific region (APR) using the Web of Science (WoS) subject category of PHC.

Methods: Academic papers in the WoS PHC category published in the APR from 2011 to 2023 were retrieved and analyzed, including papers published in the Science Citation Index-Expanded and the Social Science Citation Index.

Results: A total of 5172 papers were published in the WoS PHC category from APR onwards. The annual number of publications and their citations increased from 2011 to 2023. Australia led PHC publications in the APR with 3918 publications (75.75% of APR regional output). New Zealand had the highest number of citations per paper (14.54) and the highest mean impact factor (3.25 ± 1.70). Publications in the WoS PHC category also covered a wide range of topics, including Medicine General Internal (70.86%), Health Care Sciences Services (18.10%), Health Policy Services (17.67%), and Public Environmental Occupational Health (17.67%), demonstrating the breadth of PHC research.

Conclusion: The annual number of publications and their citations in the WoS PHC category from the APR increased from 2011 to 2023. Australia and New Zealand have a significant presence in the PHC publications in the APR.

背景:强调初级卫生保健(PHC)是实现全民健康覆盖最有效和最经济的方法,应作为其基础。本研究的目的是利用Web of Science (WoS)的PHC主题类别,对2011年至2023年亚太地区(APR)的学术出版物进行研究。方法:检索并分析2011 - 2023年《APR》发表的WoS PHC类学术论文,包括Science引文索引扩展版和Social Science引文索引。结果:4月以来WoS PHC类共发表论文5172篇。从2011年到2023年,每年的出版物数量和被引次数都有所增加。澳大利亚在亚太地区以3918篇出版物(占亚太地区产出的75.75%)领先PHC出版物。新西兰的论文引用数最高(14.54),平均影响因子最高(3.25±1.70)。世界卫生组织初级保健类别的出版物也涵盖了广泛的主题,包括内科综合医学(70.86%)、卫生保健科学服务(18.10%)、卫生政策服务(17.67%)和公共环境职业健康(17.67%),显示了初级保健研究的广度。结论:从2011年到2023年,APR WoS PHC类年度出版物数量和被引频次均有所增加。澳大利亚和新西兰在亚太地区的初级保健出版物中占有重要地位。
{"title":"A bibliometric analysis of primary health care publication trends in the Asia-Pacific region from 2011 to 2023.","authors":"Chun-Feng Huang, Brian Bih-Jeng Chang, I-Hsuan Hwang, Yu-Chun Chen, Shinn-Jang Hwang","doi":"10.1016/j.jfma.2025.02.028","DOIUrl":"10.1016/j.jfma.2025.02.028","url":null,"abstract":"<p><strong>Background: </strong>Emphasis on primary health care (PHC) is the most efficient and economical approach to achieving universal health coverage, and should serve as its foundation. The aim of the study is to examine academic publications from 2011 to 2023 in the Asia-Pacific region (APR) using the Web of Science (WoS) subject category of PHC.</p><p><strong>Methods: </strong>Academic papers in the WoS PHC category published in the APR from 2011 to 2023 were retrieved and analyzed, including papers published in the Science Citation Index-Expanded and the Social Science Citation Index.</p><p><strong>Results: </strong>A total of 5172 papers were published in the WoS PHC category from APR onwards. The annual number of publications and their citations increased from 2011 to 2023. Australia led PHC publications in the APR with 3918 publications (75.75% of APR regional output). New Zealand had the highest number of citations per paper (14.54) and the highest mean impact factor (3.25 ± 1.70). Publications in the WoS PHC category also covered a wide range of topics, including Medicine General Internal (70.86%), Health Care Sciences Services (18.10%), Health Policy Services (17.67%), and Public Environmental Occupational Health (17.67%), demonstrating the breadth of PHC research.</p><p><strong>Conclusion: </strong>The annual number of publications and their citations in the WoS PHC category from the APR increased from 2011 to 2023. Australia and New Zealand have a significant presence in the PHC publications in the APR.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":" ","pages":"454-458"},"PeriodicalIF":2.5,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143542463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Formosan Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1